{"id":6737,"date":"2025-05-19T17:02:17","date_gmt":"2025-05-19T15:02:17","guid":{"rendered":"https:\/\/www.institut-biotherapies.fr\/?p=6737"},"modified":"2026-02-19T17:03:32","modified_gmt":"2026-02-19T15:03:32","slug":"gene-therapy-two-year-consolidated-results-from-genethons-clinical-trial-for-duchenne-muscular-dystrophy","status":"publish","type":"post","link":"https:\/\/www.institut-biotherapies.fr\/en\/2025\/05\/19\/gene-therapy-two-year-consolidated-results-from-genethons-clinical-trial-for-duchenne-muscular-dystrophy\/","title":{"rendered":"Gene Therapy: Two-Year Consolidated Results from Genethon\u2019s Clinical Trial for Duchenne Muscular Dystrophy"},"content":{"rendered":"<p>Presented on May 17 at the 2025 Annual Meeting of the American Society of Gene &amp; Cell Therapy (ASGCT), the results of Genethon\u2019s trial for Duchenne Muscular Dystrophy show stabilization of motor functions and a significant, sustained reduction in CPK levels in patients treated at the effective dose. The pivotal phase is scheduled to begin mid-2025 in Europe and the United States.<\/p>\n<p><a href=\"https:\/\/www.afm-telethon.fr\/en\/news\/gene-therapy-two-year-consolidated-results-genethons-clinical-trial-duchenne-muscular\">Read more<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Presented on May 17 at the 2025 Annual Meeting of the American Society of Gene &amp; Cell Therapy (ASGCT), the results of Genethon\u2019s trial for Duchenne Muscular Dystrophy show stabilization of motor functions and a significant, sustained reduction in CPK levels in patients treated at the effective dose. The pivotal phase is scheduled to begin &hellip; <a href=\"https:\/\/www.institut-biotherapies.fr\/en\/2025\/05\/19\/gene-therapy-two-year-consolidated-results-from-genethons-clinical-trial-for-duchenne-muscular-dystrophy\/\">[Read more]<\/a><\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[],"class_list":["post-6737","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/posts\/6737","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/comments?post=6737"}],"version-history":[{"count":2,"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/posts\/6737\/revisions"}],"predecessor-version":[{"id":6739,"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/posts\/6737\/revisions\/6739"}],"wp:attachment":[{"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/media?parent=6737"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/categories?post=6737"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.institut-biotherapies.fr\/en\/wp-json\/wp\/v2\/tags?post=6737"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}